XML 28 R12.htm IDEA: XBRL DOCUMENT

Note 7 - Subsequent Events	3 Months Ended
Note 7 - Subsequent Events	Mar. 31, 2013
Subsequent Events [Text Block]	Note 7. Subsequent Events On April 2, 2013, the Company along with Bess Royalty, LP purchased a royalty stream paid on the net sales of Besivance®, an ophthalmic antibiotic, from InSite Vision, Inc. for $15 million. Besivance is marketed globally by Bausch & Lomb. The Company funded $6 million of the purchase price at closing to own 40.1325% of the royalty stream.